Mediware Acquires Transtem to Expand With Cellular Therapy Software; Terms Not Disclosed
Mediware® Information Systems, Inc. (Nasdaq: MEDW) today announced that it has acquired substantially all the assets of St. Louis-based Transtem, LLC, a provider of software that manages the collection and transplantation of adult stem cells in cellular-based therapies and medical research.
The acquisition continues the expansion of Mediware's blood management expertise and extends the company with software and domain expertise in a rapidly growing field that includes cancer treatment and regenerative medicine. Details related to the acquisition were not released.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.